Ventripoint Diagnostics Ltd. (TSXV:VPT; OTC:VPTDF) has announced a strategic collaboration with the Ollie Hinkle Heart Foundation (OHHF) to expand access to AI-powered cardiac imaging for children and adults living with congenital and childhood-onset heart disease. The partnership combines Ventripoint's VMS+™ platform, which uses artificial intelligence to provide accurate measurements of heart structure and function from standard echocardiograms, with OHHF's Take Heart Collective Impact Model, a framework that unites healthcare providers, innovators, researchers, patients, families, and social partners such as Jovie's Joy and Ella's Umbrella.
Under the collaboration, OHHF will initially provide financial support to place two VMS+™ systems within its healthcare partner network. The initiative also includes opportunities for education, advocacy, research, technology adoption, and community engagement. The VMS+™ platform is designed to enhance clinical decision-making and support ongoing patient monitoring by delivering sophisticated cardiac insights in a more accessible and efficient manner, expanding access to advanced cardiac assessment across a range of heart conditions.
“Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging,” said Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint Diagnostics. “Ollie Hinkle Heart Foundation has become a respected leader in bringing together families, clinicians, healthcare systems, and innovators to solve complex challenges facing children and families impacted by heart disease. Together, we have an opportunity to expand access to advanced imaging solutions that help clinicians make more informed decisions and improve care throughout a patient's journey.”
The partnership is rooted in the lived experiences of families who understand the importance of better information, safer testing options, and more informed treatment decisions. Katie Nesselbush, Founder of Jovie's Joy and Social Partner of OHHF, shared her perspective as a mother of a child with dilated cardiomyopathy: “I know firsthand the impossible decisions families can face when trying to get answers about their child's heart. Technologies like Ventripoint give physicians more information to guide care while reducing barriers and risk for families. Every parent wants confidence that they're making the best possible decisions for their child, and every child deserves access to the most advanced tools available.”
Mark Hinkle, Co-Founder of OHHF, reflected on the foundation's motivation: “When our son Ollie passed away at just 13 months old, we learned firsthand how quickly a child's condition can change. We can't change Ollie's story, and we can't bring Ella back. But we can honor them by ensuring more children have access to the technology, information, and treatment options they never had. That's the future we're building through the Take Heart Collective Impact Model.”
The collaboration between Ventripoint, OHHF, Jovie's Joy, and Ella's Umbrella demonstrates how lived experience and innovation can work together to expand access to advanced cardiac imaging for children living with heart disease. Ventripoint's VMS+™ platform is already supported by regulatory market approvals in the U.S., Europe, and Canada.
